Cat.#: ACPP-1385
| Despition | Transforming Growth Factor Beta Induced Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile filtered liquid formulation. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1468 | Human MEIS3 Protein (AC1468) | 5 µg | inquiry |
| ACPP-1069 | Calretinin Blocking Peptide (AC1069) | 250 µg | inquiry |
| ACPP-1523 | RPE65 Blocking Peptide (AC1523) | 250 µg | inquiry |
| ACPP-1345 | DISC1 Blocking Peptide (AC1345) | 250 µg | inquiry |
| ACPP-1458 | Mouse LGALS3 Protein (AC1458) | 2 µg | inquiry |
| ACPP-1807 | Human QKI Protein (AC1807) | 2 µg | inquiry |
| ACPP-1191 | Nogo Blocking Peptide (AC1191) | 250 µg | inquiry |
| ACPP-1793 | Human HSPB8 Protein, His (AC1793) | 2 µg | inquiry |
| ACPP-1405 | Human Ciliary Neurotrophic Factor (Active) Protein (AC1405) | 100 µg | inquiry |
| ACPP-1164 | Synthetic Nanodisc Human GRPR Protein (AC1164) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.